Clinical Trials · NCT03809429
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 437
- Start date
- Apr 2019
- Locations
- 16 sites, 7 countries
- Primary endpoint
- Number of Oocytes Retrieved